Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Miller

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly scheduleJ R Rigas, P A Francis, V A Miller, et al.
Cancer|February 15, 1995
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerV A Miller, J R Rigas, P A Francis, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)M G Kris, K M Pisters, R J Ginsberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumorsJ R Rigas, M G Kris, V A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancerL M Krug, V A Miller, G P Kalemkerian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancerM N Dickler, G Ragupathi, N X Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolateL M Krug, K K Ng, M G Kris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acidV A Miller, J R Rigas, F M Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069V A Miller, F M Benedetti, J R Rigas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly scheduleJ R Rigas, P A Francis, V A Miller, et al.
Cancer|February 15, 1995
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerV A Miller, J R Rigas, P A Francis, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)M G Kris, K M Pisters, R J Ginsberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumorsJ R Rigas, M G Kris, V A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancerL M Krug, V A Miller, G P Kalemkerian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancerM N Dickler, G Ragupathi, N X Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolateL M Krug, K K Ng, M G Kris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acidV A Miller, J R Rigas, F M Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069V A Miller, F M Benedetti, J R Rigas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
Pageof 6